Literature DB >> 16185605

[5-Fluorouracil-induced small bowel toxicity in a patient with colorectal cancer].

Cristina Llorca Ferrándiz1, Gaspar Esquerdo Galiana, José Manuel Cervera Grau, Hugo Claudio Briceño García, Juan Vicente Calduch Broseta, José Del Pino Cuadrado.   

Abstract

5-Fluorouracil-induced gastro-intestinal toxicity predominantly affects the upper and the lower gastro-intestinal tract. Although 5-fluorouracil (5-FU) can cause severe small-bowel toxicity, this has been reported only in 6 patients with colon carcinoma receiving 5-FU-based therapy. The presentation was extensive ulceration and inflammation of the small bowel with no involvement of the colon. We report another case of this toxicity, and discuss the diagnosis and mechanisms by which 5-FU can induce small-bowel toxicity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16185605     DOI: 10.1007/bf02716552

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  10 in total

1.  5-fluorouracil toxicity: old or new?

Authors:  B J Kennedy
Journal:  Cancer       Date:  1999-10-01       Impact factor: 6.860

2.  5-fluorouracil-induced small bowel toxicity in patients with colorectal carcinoma.

Authors:  J Lokich
Journal:  Cancer       Date:  2000-05-15       Impact factor: 6.860

3.  5-fluorouracil-induced small bowel toxicity in patients with colorectal carcinoma.

Authors:  M Cwikiel; M Albertsson; S Kinhult; J Eskilsson
Journal:  Cancer       Date:  2000-08-01       Impact factor: 6.860

4.  5-fluorouracil-induced small bowel toxicity in patients with colorectal carcinoma.

Authors:  F Fata; I G Ron; N Kemeny; E O'Reilly; D Klimstra; D P Kelsen
Journal:  Cancer       Date:  1999-10-01       Impact factor: 6.860

5.  Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer.

Authors:  M J O'Connell; J A Mailliard; M J Kahn; J S Macdonald; D G Haller; R J Mayer; H S Wieand
Journal:  J Clin Oncol       Date:  1997-01       Impact factor: 44.544

6.  Haematological and non-haematological toxicity after 5-fluorouracil and leucovorin in patients with advanced colorectal cancer is significantly associated with gender, increasing age and cycle number. Tomudex International Study Group.

Authors:  J Zalcberg; D Kerr; L Seymour; M Palmer
Journal:  Eur J Cancer       Date:  1998-11       Impact factor: 9.162

Review 7.  American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.

Authors:  Al B Benson; Deborah Schrag; Mark R Somerfield; Alfred M Cohen; Alvaro T Figueredo; Patrick J Flynn; Monika K Krzyzanowska; Jean Maroun; Pamela McAllister; Eric Van Cutsem; Melissa Brouwers; Manya Charette; Daniel G Haller
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

8.  Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report.

Authors:  C G Moertel; T R Fleming; J S Macdonald; D G Haller; J A Laurie; C M Tangen; J S Ungerleider; W A Emerson; D C Tormey; J H Glick; M H Veeder; J A Mailliard
Journal:  Ann Intern Med       Date:  1995-03-01       Impact factor: 25.391

Review 9.  The syndrome of 5-fluorouracil cardiotoxicity. An elusive cardiopathy.

Authors:  N C Robben; A W Pippas; J O Moore
Journal:  Cancer       Date:  1993-01-15       Impact factor: 6.860

10.  Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors.

Authors:  E Lévy; P Piedbois; M Buyse; J P Pignon; P Rougier; L Ryan; R Hansen; B Zee; B Weinerman; J Pater; C Leichman; J Macdonald; J Benedetti; J Lokich; J Fryer; G Brufman; R Isacson; A Laplanche; E Quinaux; P Thirion
Journal:  J Clin Oncol       Date:  1998-11       Impact factor: 44.544

  10 in total
  2 in total

1.  Poly(butylcyanoacrylate) and Poly(ε-caprolactone) Nanoparticles Loaded with 5-Fluorouracil Increase the Cytotoxic Effect of the Drug in Experimental Colon Cancer.

Authors:  Raúl Ortiz; Laura Cabeza; José L Arias; Consolación Melguizo; Pablo J Álvarez; Celia Vélez; Beatriz Clares; Antonia Áranega; Jose Prados
Journal:  AAPS J       Date:  2015-04-17       Impact factor: 4.009

2.  Preparation of chitosan-polyaspartic acid-5-fluorouracil nanoparticles and its anti-carcinoma effect on tumor growth in nude mice.

Authors:  Dan-Ying Zhang; Xi-Zhong Shen; Ji-Yao Wang; Ling Dong; Yong-Li Zheng; Li-Li Wu
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.